GOLDMAN SACHS GROUP INC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$19,397,000
+1475.7%
147,421
+505.2%
0.01%
Q3 2020$1,231,000
-19.5%
24,359
-24.1%
0.00%
Q2 2020$1,530,000
-10.4%
32,100
-7.9%
0.00%
-100.0%
Q1 2020$1,708,000
-41.6%
34,867
-31.6%
0.00%0.0%
Q4 2019$2,927,000
+122.4%
50,998
+39.4%
0.00%
Q3 2019$1,316,000
+126.9%
36,594
+96.1%
0.00%
Q2 2019$580,000
+25.3%
18,665
-5.4%
0.00%
Q1 2019$463,000
+21.2%
19,728
-29.0%
0.00%
Q4 2018$382,000
+156.4%
27,790
+85.9%
0.00%
Q3 2018$149,000
-76.9%
14,951
-52.8%
0.00%
Q2 2018$645,00031,6920.00%
Other shareholders

There were no reported owners of EIDOS THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of EIDOS THERAPEUTICS INC shareholders